SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Trinity Biotech (TRIBY) -- Ignore unavailable to you. Want to Upgrade?


To: Mark Catalano who wrote (7635)12/31/1997 6:07:00 AM
From: Bill Coenen  Respond to of 14328
 
Mark,
I think you answered your own question. Compare the fundamentals of the two companies and their posture for increased future earnings. In the long haul that should defeat the MM's and their shananigans.
I must not be as smart as the rest of you because in most of my investments it takes me two to three years before things really start to pan out. Realize that there is only a limited amount of air breathing time for us all, but like good wine, I don't know how you rush it. Hope 98 is a good one for you. Bill



To: Mark Catalano who wrote (7635)12/31/1997 12:07:00 PM
From: DMore  Read Replies (1) | Respond to of 14328
 
SALV is a joke. Horrible product, balance sheet and management.
While we may not like it TRIBY management is building a
company first and the stock will take care of itself. I have
owned many small companies before and patience is the key.
My biggest blunder was selling ANLT early. This stock could
not break $4, when it did I sold at $6. Today, it is $32 after
splits. This company is very similar to TRIBY growth wise
and unknown to the investment community. The key is to buy
before the investment community discovers it.
Good luck.
D